NASDAQ: TNGX
Tango Therapeutics Inc Stock Ownership - Who owns Tango Therapeutics?

Insider buying vs selling

Have Tango Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Adam CrystalPresident RD2026-05-011,100$22.00
$24.20kSell
Adam CrystalPresident RD2026-05-0127,000$5.20
$140.40kBuy
Adam CrystalPresident RD2026-05-0125,900$21.19
$548.90kSell
Adam CrystalPresident RD2026-04-1538,460$25.00
$961.50kSell
Adam CrystalPresident RD2026-04-1538,460$5.20
$199.99kBuy
Adam CrystalPresident RD2026-04-0127,000$5.20
$140.40kBuy
Adam CrystalPresident RD2026-04-0127,000$21.20
$572.48kSell
Adam CrystalPresident RD2026-03-2512,000$5.20
$62.40kBuy
Adam CrystalPresident RD2026-03-2512,000$20.11
$241.32kSell
Adam CrystalPresident RD2026-03-0520,251$15.00
$303.77kSell

1 of 3

TNGX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TNGX insiders and whales buy or sell their stock.

TNGX Shareholders

What type of owners hold Tango Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ecor1 Capital LLC16.79%23,961,472$562.62MInsider
Boxer Capital LLC10.64%15,187,092$356.59MInsider
Boxer Capital Management LLC9.59%13,679,092$321.19MInsider
Third Rock Ventures IV LP9.38%13,386,574$314.32MInsider
Farallon Capital Management LLC9.15%13,061,411$306.68MInstitution
Tcg Crossover Management LLC8.94%12,762,094$299.65MInstitution
Boxer Capital Management LLC7.62%10,876,219$255.37MInstitution
Adage Capital Partners GP LLC7.43%10,607,924$249.07MInstitution
Woodline Partners LP7.06%10,072,225$236.50MInstitution
Blackrock Inc5.99%8,540,797$200.54MInstitution

1 of 3

TNGX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TNGX67.43%32.57%Net SellingNet Selling
BEAM86.28%13.72%Net SellingNet Selling
ERAS70.51%27.66%Net BuyingNet Buying
ORKA25.56%74.44%Net BuyingNet Selling
TLX0.33%7.56%Net BuyingNet Buying

Tango Therapeutics Stock Ownership FAQ

Who owns Tango Therapeutics?

Tango Therapeutics (NASDAQ: TNGX) is owned by 120.82% institutional shareholders, 58.37% Tango Therapeutics insiders, and 0.00% retail investors. Ecor1 Capital LLC is the largest individual Tango Therapeutics shareholder, owning 23.96M shares representing 16.79% of the company. Ecor1 Capital LLC's Tango Therapeutics shares are currently valued at $563.09M.

If you're new to stock investing, here's how to buy Tango Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.